BioDisruption: The Digest’s 2018 Multi-Slide Guide to Amyris
For many people, a key question in the advanced bioeconomy is: “what is Amyris becoming, and when, and where and how?” Becoming a global leader in the health and beauty market, and self-funding operations in 2018 with at least $10 million in EBITDA this year — those are the answers appearing out of Emeryville now. […]









